Evaluation of efficacy in improvement of cardiac function / renal function by REZALTAS COMBINATION TABLETS on hypertension patient.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Olmesartan medoxomil/azelnidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 12 May 2016 Last checked against University Hospital Medical Information Network - Japan record.
- 28 Feb 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 08 Mar 2011 New trial record